IBM Retirement Fund lowered its position in shares of Danaher Co. (NYSE:DHR) by 6.4% during the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 10,611 shares of the conglomerate’s stock after selling 725 shares during the period. IBM Retirement Fund’s holdings in Danaher were worth $1,094,000 as of its most recent filing with the Securities and Exchange Commission.
Several other hedge funds and other institutional investors have also recently made changes to their positions in the company. Vanguard Group Inc increased its stake in shares of Danaher by 1.4% during the third quarter. Vanguard Group Inc now owns 44,738,984 shares of the conglomerate’s stock worth $4,861,338,000 after purchasing an additional 605,018 shares during the period. BlackRock Inc. grew its position in Danaher by 0.5% during the fourth quarter. BlackRock Inc. now owns 43,634,997 shares of the conglomerate’s stock worth $4,499,639,000 after buying an additional 207,468 shares in the last quarter. FMR LLC grew its position in Danaher by 3.5% during the third quarter. FMR LLC now owns 21,739,751 shares of the conglomerate’s stock worth $2,362,241,000 after buying an additional 728,725 shares in the last quarter. Geode Capital Management LLC grew its position in Danaher by 8.4% during the fourth quarter. Geode Capital Management LLC now owns 7,527,142 shares of the conglomerate’s stock worth $774,743,000 after buying an additional 583,194 shares in the last quarter. Finally, Oregon Public Employees Retirement Fund grew its position in Danaher by 10,085.3% during the fourth quarter. Oregon Public Employees Retirement Fund now owns 6,863,048 shares of the conglomerate’s stock worth $67,000 after buying an additional 6,795,666 shares in the last quarter. Institutional investors own 78.29% of the company’s stock.
Shares of DHR stock opened at $128.69 on Friday. The firm has a market capitalization of $90.32 billion, a price-to-earnings ratio of 28.47, a price-to-earnings-growth ratio of 2.35 and a beta of 1.04. Danaher Co. has a fifty-two week low of $94.59 and a fifty-two week high of $129.42. The company has a debt-to-equity ratio of 0.34, a quick ratio of 1.07 and a current ratio of 1.47.
Danaher (NYSE:DHR) last issued its earnings results on Tuesday, January 29th. The conglomerate reported $1.28 earnings per share for the quarter, beating the Zacks’ consensus estimate of $1.27 by $0.01. The firm had revenue of $5.40 billion for the quarter, compared to the consensus estimate of $5.33 billion. Danaher had a return on equity of 11.64% and a net margin of 13.33%. The company’s revenue was up 6.2% compared to the same quarter last year. During the same quarter last year, the business posted $1.19 EPS. On average, analysts forecast that Danaher Co. will post 4.76 earnings per share for the current year.
The firm also recently announced a quarterly dividend, which will be paid on Friday, April 26th. Shareholders of record on Friday, March 29th will be issued a $0.17 dividend. This represents a $0.68 dividend on an annualized basis and a dividend yield of 0.53%. The ex-dividend date is Thursday, March 28th. This is an increase from Danaher’s previous quarterly dividend of $0.16. Danaher’s dividend payout ratio (DPR) is currently 14.16%.
In related news, insider Rainer Blair sold 37,859 shares of the firm’s stock in a transaction on Wednesday, February 27th. The stock was sold at an average price of $127.45, for a total transaction of $4,825,129.55. Following the sale, the insider now owns 32,661 shares of the company’s stock, valued at approximately $4,162,644.45. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, EVP Daniel L. Comas sold 97,357 shares of the firm’s stock in a transaction on Wednesday, February 27th. The shares were sold at an average price of $127.04, for a total value of $12,368,233.28. Following the sale, the executive vice president now directly owns 134,039 shares in the company, valued at approximately $17,028,314.56. The disclosure for this sale can be found here. In the last ninety days, insiders sold 183,150 shares of company stock worth $23,279,637. Company insiders own 11.90% of the company’s stock.
A number of equities research analysts recently issued reports on DHR shares. Needham & Company LLC reissued a “buy” rating and set a $138.00 price target (up previously from $114.00) on shares of Danaher in a research report on Thursday, February 28th. Jefferies Financial Group increased their price target on Danaher to $140.00 and gave the stock a “buy” rating in a research report on Tuesday, February 26th. Deutsche Bank increased their price target on Danaher to $130.00 and gave the stock a “buy” rating in a research report on Tuesday, February 26th. UBS Group increased their price target on Danaher from $125.00 to $144.00 and gave the stock a “buy” rating in a research report on Tuesday, February 26th. Finally, Janney Montgomery Scott raised Danaher from a “neutral” rating to a “buy” rating in a research report on Monday, February 25th. Two equities research analysts have rated the stock with a hold rating and thirteen have assigned a buy rating to the company. The stock presently has a consensus rating of “Buy” and a consensus target price of $123.31.
COPYRIGHT VIOLATION NOTICE: “IBM Retirement Fund Sells 725 Shares of Danaher Co. (DHR)” was first posted by Transcript Daily and is the sole property of of Transcript Daily. If you are accessing this story on another publication, it was stolen and reposted in violation of United States and international copyright legislation. The correct version of this story can be accessed at https://transcriptdaily.com/2019/03/17/ibm-retirement-fund-sells-725-shares-of-danaher-co-dhr.html.
Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company's Life Sciences segment provides laser scanning, compound, surgical, and other stereo microscopes. This segment also offers filtration, separation, and purification technologies to the biopharmaceutical, food and beverage, medical, aerospace, microelectronics, and general industrial sectors.
Featured Story: How much can an individual set aside as a catch-up contribution?
Want to see what other hedge funds are holding DHR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Danaher Co. (NYSE:DHR).
Receive News & Ratings for Danaher Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher and related companies with MarketBeat.com's FREE daily email newsletter.